Short-acting heparin-based anticoagulant compounds and methods
US11701380B2 · kind B2 · utility
0Cited by
14References
42Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 12, 2018 |
| Grant date | Jul 18, 2023 |
| Priority date | — |
| Expiry date | Mar 12, 2038 |
Classification
- Technology area (CPC —)General
Abstract
Heparin compounds and synthetic heparin analogues having short acting anticoagulant activity are provided. Methods of synthesizing such heparin compounds, including chemoenzymatic pathways using sulfotransferase enzymes are provided. Methods of treating subjects in need of anticoagulant activity are provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.